Refine
Year of publication
Has Fulltext
- yes (1115)
Is part of the Bibliography
- no (1115)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- pp collisions (3)
- Beauty production (2)
- Bevorratung (2)
- COVID-19 (2)
- Cancer (2)
- Charm physics (2)
- Diagnostik (2)
- Epilepsy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Heart failure (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Mammakarzinom (2)
- Nachsorge (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- Quality of care (2)
- Quasi-free scattering (2)
- Relativistic heavy-ion collisions (2)
- Rheumatoid arthritis (2)
- Richtlinie (2)
- SARS-CoV-2 (2)
- Seizure (2)
- Shell model (2)
- Single electrons (2)
- breast cancer (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- screening (2)
- 900 GeV (1)
- ABS (1)
- ALICE detector (1)
- ALK (1)
- Abusive head trauma (AHT) (1)
- Africa (1)
- Afrika (1)
- Anatomic competence (1)
- Angiomyolipoma (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Antibiotic stewardship (1)
- Anticonvulsant (1)
- Antimicrobial resistance (1)
- Aortic valve (1)
- Apoptosis (1)
- Artesunate (1)
- Arthroscopy (1)
- Asia (1)
- Asien (1)
- Atherosclerosis (1)
- BESIII (1)
- Bayesian inference (1)
- Benign enlargement of the subarachnoid spaces (BESS) (1)
- Biological control (1)
- Blood pressure (1)
- Body mass index (1)
- Boosted Jets (1)
- Brain tumors (1)
- Branching fractions (1)
- CHEPs (1)
- Cancer genetics (1)
- Cancer genomics (1)
- Capsaicin (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Cardiology (1)
- Centrality Class (1)
- Centrality Selection (1)
- Cerebral toxoplasmosis HIV (1)
- Charge fluctuations (1)
- Children and adolescents (1)
- Chronic obstructive pulmonary disease (1)
- Clinical pathways (1)
- Clinical study (1)
- Collective Flow, (1)
- Comparison with QCD (1)
- Consensus document (1)
- Costs (1)
- Cross sections (1)
- Death rates (1)
- Depression (1)
- Diagnosis (1)
- Differential diagnosis (1)
- Direct nuclear reactions (1)
- Direct reactions (1)
- D⁰ meson (1)
- Education (1)
- Ejection fraction (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Emotions (1)
- Endothelial cells (1)
- Europe (1)
- Everolimus (1)
- Exercise training (1)
- Experimental models of disease (1)
- Falciparum (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- First-line regimen (1)
- Forschung (1)
- Genetics (1)
- Genomic instability (1)
- Guideline (1)
- HBT (1)
- HER2 c-erbB2 (1)
- HER2/neu (1)
- HIV (1)
- HNO (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hadronic decays (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Head and neck Cancer (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- High-energy neutron detection (1)
- Idiobiont (1)
- Implantable cardioverter-defibrillator (1)
- Inclusive spectra (1)
- Inflammation (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Inverse kinematics (1)
- Ionisation energy loss (1)
- Jet Physics (1)
- Jet Substructure (1)
- Knee joint (1)
- Koinobiont (1)
- Late presentation (1)
- Lee type, functional outcome (1)
- Lehre (1)
- Leukemia (1)
- Long non-coding RNAs (1)
- Lymphadenopathy (1)
- MTOR inhibitor (1)
- MYCN amplification (1)
- Malaria (1)
- Material budget (1)
- Medical (1)
- Mental health and psychiatry (1)
- Metabolic diseases (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Molecular medicine (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-neutron detection (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Musculoskeletal ultrasound (1)
- NMR spectroscopy (1)
- NSAIDs (1)
- Natural product (1)
- Neural network (1)
- Non-abusive head trauma (NAHT) (1)
- Nuclear modification factor (1)
- Nuclear reactions (1)
- Nuclear structure & decays (1)
- Nucleolar protein 14 (1)
- Nucleon induced nuclear reactions (1)
- ORL (1)
- ORP (1)
- One-nucleon removal (1)
- Opportunistic infections (1)
- Otorhinolaryngology (1)
- Outcomes (1)
- PAD-test (1)
- PCP (1)
- PYTHIA (1)
- Pacemaker (1)
- Palaearctic (1)
- Paleoarktik (1)
- Pancreatic surgery (1)
- Pancreatoduodenectomy (1)
- Particle and Resonance Production (1)
- Patient reported outcomes (1)
- Pb–Pb (1)
- Phospholipids (1)
- Physical activity (1)
- Plasmodium (1)
- Plastic scintillator array (1)
- Pneumocystis jirovecii (1)
- Prevention (1)
- Production Cross Section (1)
- Prognosis (1)
- Properties of Hadrons (1)
- Protein synthesis (1)
- Proton–proton (1)
- Psychometrics (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Questionnaires (1)
- Quinine (1)
- RARP (1)
- RAS pathway (1)
- Randomized controlled trial (1)
- Rapidity Range (1)
- Rational use (1)
- Reactions with relativistic radioactive beams (1)
- Regulatory networks (1)
- Relativistic heavy ion physics (1)
- Research (1)
- Residency (1)
- Resolution Parameter (1)
- Rhabdomyoma (1)
- Rheumatology (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- Salivary gland diseases (1)
- Sarcomas (1)
- Severe malaria (1)
- Shoulder joint (1)
- Single muons (1)
- Social participation (1)
- Sociodemographic characteristics (1)
- Specialist training (1)
- Spectroscopic factors (1)
- Spectroscopic factors & electromagnetic moments (1)
- Structured reporting (1)
- Students (1)
- Subependymal giant cell astrocytoma (1)
- Systematic Uncertainty (1)
- T-DM1 (1)
- T. pintoi (1)
- T. semblidis (1)
- TR (1)
- TSC (1)
- Teaching (1)
- Thrombosis (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Treatment (1)
- Treatment modification (1)
- Trichogramma chilonis (1)
- Trigger (1)
- Ultrasonography (1)
- University hospitals (1)
- Universitätskliniken (1)
- Vector Boson Production (1)
- Vioprolide A (1)
- Vorratsschutz (1)
- Weiterbildung (1)
- Wirtserkennung (1)
- Xenon-based gas mixture (1)
- accessory proteins (1)
- acupuncture (1)
- acute coronary syndrome (1)
- acute-on-chronic liver failure (1)
- advanced breast cancer (1)
- aging (1)
- amino acid PET (1)
- animal experiments (1)
- antibiotic therapy (1)
- antihormone therapy (1)
- artificial intelligence (1)
- astroglia (1)
- biological control (1)
- biologische Bekämpfung (1)
- biologische Kontrolle (1)
- bortezomib (1)
- cART (1)
- cell-free protein synthesis (1)
- chemotherapy (1)
- clinical pathways (1)
- copeptin (1)
- cytokines (1)
- dE/dx (1)
- detector (1)
- endothelin (1)
- endothelin receptor type A antagonist (1)
- erythropoietin (1)
- exercise therapy (1)
- experimental results (1)
- gastric surgery (1)
- glioma (1)
- heavy ion experiments (1)
- high-risk neuroblastoma (1)
- host-finding (1)
- hypoxia (1)
- idiobiont (1)
- imaging (1)
- induction regimen (1)
- infections: pneumonia, TB, viral (1)
- inflammation (1)
- interferons (1)
- intranasal administration (1)
- intrinsically disordered region (1)
- kidney (1)
- koinobiont (1)
- lapatinib (1)
- lenalidomide (1)
- liver cirrhosis (1)
- liver immunology (1)
- mTOR inhibitor (1)
- macrophages (1)
- medical training (1)
- metastatic (1)
- mice (1)
- monoclonal antibody (1)
- mortality (1)
- multiple myeloma (1)
- myocardial infarction (1)
- neuroprotection (1)
- neutralizing antibody (1)
- nonstructural proteins (1)
- oncological gastrectomy (1)
- outcomes (1)
- p53 pathway (1)
- pertuzumab (1)
- quality of care (1)
- quark gluon plasma (1)
- registry (1)
- renal failure (1)
- resectability (1)
- spectra (1)
- standardization (1)
- stored grain (1)
- stored product protection (1)
- stored products (1)
- structural proteins (1)
- tension type headache (1)
- topical administration (1)
- traditional Chinese medicine (1)
- transduction (1)
- trastuzumab (1)
- treatment-related changes (1)
- troponin (1)
- tumor progression (1)
- virus (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1052)
- Frankfurt Institute for Advanced Studies (FIAS) (959)
- Informatik (924)
- Medizin (51)
- ELEMENTS (6)
- Informatik und Mathematik (3)
- Biochemie, Chemie und Pharmazie (2)
- Geowissenschaften (2)
- Hochschulrechenzentrum (2)
- Pharmazie (2)
Microangiopathy with subsequent organ damage represents a major complication in several diseases. The mechanisms leading to microvascular occlusion include von Willebrand factor (VWF), notably the formation of ultra-large von Willebrand factor fibers (ULVWFs) and platelet aggregation. To date, the contribution of erythrocytes to vascular occlusion is incompletely clarified. We investigated the platelet-independent interaction between stressed erythrocytes and ULVWFs and its consequences for microcirculation and organ function under dynamic conditions. In response to shear stress, erythrocytes interacted strongly with VWF to initiate the formation of ULVWF/erythrocyte aggregates via the binding of Annexin V to the VWF A1 domain. VWF-erythrocyte adhesion was attenuated by heparin and the VWF-specific protease ADAMTS13. In an in vivo model of renal ischemia/reperfusion injury, erythrocytes adhered to capillaries of wild-type but not VWF-deficient mice and later resulted in less renal damage. In vivo imaging in mice confirmed the adhesion of stressed erythrocytes to the vessel wall. Moreover, enhanced eryptosis rates and increased VWF binding were detected in blood samples from patients with chronic renal failure. Our study demonstrates that stressed erythrocytes have a pronounced binding affinity to ULVWFs. The discovered mechanisms suggest that erythrocytes are essential for the pathogenesis of microangiopathies and renal damage by actively binding to ULVWFs.
Oxidized phospholipids (oxPAPC) induce endothelial dysfunction and atherosclerosis. Here we show that oxPAPC induce a gene network regulating serine-glycine metabolism with the mitochondrial methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2) as a causal regulator using integrative network modeling and Bayesian network analysis in human aortic endothelial cells. The cluster is activated in human plaque material and by atherogenic lipoproteins isolated from plasma of patients with coronary artery disease (CAD). Single nucleotide polymorphisms (SNPs) within the MTHFD2-controlled cluster associate with CAD. The MTHFD2-controlled cluster redirects metabolism to glycine synthesis to replenish purine nucleotides. Since endothelial cells secrete purines in response to oxPAPC, the MTHFD2-controlled response maintains endothelial ATP. Accordingly, MTHFD2-dependent glycine synthesis is a prerequisite for angiogenesis. Thus, we propose that endothelial cells undergo MTHFD2-mediated reprogramming toward serine-glycine and mitochondrial one-carbon metabolism to compensate for the loss of ATP in response to oxPAPC during atherosclerosis.
Purpose: Scientific and clinical achievements in radiation, medical, and surgical oncology are changing the landscape of interdisciplinary oncology. The German Society for Radiation Oncology (DEGRO) working group of young clinicians and scientists (yDEGRO) and the DEGRO representation of associate and full professors (AKRO) are aware of the essential role of radiation oncology in multidisciplinary treatment approaches. Together, yDEGRO and AKRO endorsed developing a German radiotherapy & radiation oncology vision 2030 to address future challenges in patient care, research, and education. The vision 2030 aims to identify priorities and goals for the next decade in the field of radiation oncology. Methods: The vision development comprised three phases. During the first phase, areas of interest, objectives, and the process of vision development were defined jointly by the yDEGRO, AKRO, and the DEGRO board. In the second phase, a one-day strategy retreat was held to develop AKRO and yDEGRO representatives’ final vision from medicine, biology, and physics. The third phase was dedicated to vision interpretation and program development by yDEGRO representatives. Results: The strategy retreat’s development process resulted in conception of the final vision “Innovative radiation oncology Together – Precise, Personalized, Human.” The first term “Innovative radiation oncology” comprises the promotion of preclinical research and clinical trials and highlights the development of a national committee for strategic development in radiation oncology research. The term “together” underpins collaborations within radiation oncology departments as well as with other partners in the clinical and scientific setting. “Precise” mainly covers technological precision in radiotherapy as well as targeted oncologic therapeutics. “Personalized” emphasizes biology-directed individualization of radiation treatment. Finally, “Human” underlines the patient-centered approach and points towards the need for individual longer-term career curricula for clinicians and researchers in the field. Conclusion: The vision 2030 balances the ambition of physical, technological, and biological innovation as well as a comprehensive, patient-centered, and collaborative approach towards radiotherapy & radiation oncology in Germany.
Hintergrund: Ab Frühjahr 2020 kam es zur weltweiten Verbreitung von SARS-CoV‑2 mit der heute als erste Welle der Pandemie bezeichneten Phase ab März 2020. Diese resultierte an vielen Kliniken in Umstrukturierungen und Ressourcenverschiebungen. Ziel unserer Arbeit war die Erfassung der Auswirkungen der Pandemie auf die universitäre Hals-Nasen-Ohren(HNO)-Heilkunde für die Forschung, Lehre und Weiterbildung. Material und Methoden: Die Direktorinnen und Direktoren der 39 Universitäts-HNO-Kliniken in Deutschland wurden mithilfe einer strukturierten Online-Befragung zu den Auswirkungen der Pandemie im Zeitraum von März bis April 2020 auf die Forschung, Lehre und die Weiterbildung befragt. Ergebnisse: Alle 39 Direktorinnen und Direktoren beteiligten sich an der Umfrage. Hiervon gaben 74,4 % (29/39) an, dass es zu einer Verschlechterung ihrer Forschungstätigkeit infolge der Pandemie gekommen sei. Von 61,5 % (24/39) wurde berichtet, dass pandemiebezogene Forschungsaspekte aufgegriffen wurden. Von allen Kliniken wurde eine Einschränkung der Präsenzlehre berichtet und 97,5 % (38/39) führten neue digitale Lehrformate ein. Im Beobachtungszeitraum sahen 74,4 % der Klinikdirektoren die Weiterbildung der Assistenten nicht gefährdet. Schlussfolgerung: Die Ergebnisse geben einen Einblick in die heterogenen Auswirkungen der Pandemie. Die kurzfristige Bearbeitung pandemiebezogener Forschungsthemen und die Einführung innovativer digitaler Konzepte für die studentische Lehre belegt eindrücklich das große innovative Potenzial und die schnelle Reaktionsfähigkeit der HNO-Universitätskliniken, um auch während der Pandemie ihre Aufgaben in der Forschung, Lehre und Weiterbildung bestmöglich zu erfüllen.
Results are presented on event-by-event fluctuations in transverse momentum of charged particles, produced at forward rapidities in p+p, C+C, Si+Si and Pb+Pb collisions at 158 AGeV. Three different characteristics are discussed: the average transverse momentum of the event, the Phi_pT fluctuation measure and two-particle transverse momentum correlations. In the kinematic region explored, the dynamical fluctuations are found to be small. However, a significant system size dependence of Phi_pT is observed, with the largest value measured in peripheral Pb+Pb interactions. The data are compared with predictions of several models. PACS numbers: 14.20.Jn, 13.75.Cs, 12.39.-x
A non-monotonic energy dependence of the K + / pi + ratio with a sharp maximum close to 30 A GeV is observed in central Pb+Pb collisions. Within a statistical model of the early stage, this is interpreted as a sign of the phase transition to a QGP, which causes a sharp change in the energy dependence of the strangeness to entropy ratio. This observation naturally motivates us to study the production of multistrange hyperons (Xi, Omega) as a function of the beam energy. Furthermore it was suggested that the kinematic freeze-out of Omega takes place directly at QGP hadronization. If this is indeed the case, the transverse momentum spectra of the Omega directly reflect the transverse expansion velocity of a hadronizing QGP. In this report we show preliminary NA49 results on Omega - and Omega + production in central Pb+Pb collisions at 40 and 158 A GeV and compare them to measurements of Xi - and Xi + production in central Pb+Pb collisions at 30, 40, 80 and 158 A GeV.
Background: Malaria remains one of the most serious infections for travellers to tropical countries. Due to the lack of harmonized guidelines a large variety of treatment regimens is used in Europe to treat severe malaria.
Methods: The European Network for Tropical Medicine and Travel Health (TropNet) conducted an 8-year, multicentre, observational study to analyse epidemiology, treatment practices and outcomes of severe malaria in its member sites across Europe. Physicians at participating TropNet centres were asked to report pseudonymized retrospective data from all patients treated at their centre for microscopically confirmed severe Plasmodium falciparum malaria according to the 2006 WHO criteria.
Results: From 2006 to 2014 a total of 185 patients with severe malaria treated in 12 European countries were included. Three patients died, resulting in a 28-day survival rate of 98.4%. The majority of infections were acquired in West Africa (109/185, 59%). The proportion of patients treated with intravenous artesunate increased from 27% in 2006 to 60% in 2013. Altogether, 56 different combinations of intravenous and oral drugs were used across 28 study centres. The risk of acute renal failure (36 vs 17% p = 0.04) or cerebral malaria (54 vs 20%, p = 0.001) was significantly higher in patients ≥60 years than in younger patients. Respiratory distress with the need for mechanical ventilation was significantly associated with the risk of death in the study population (13 vs 0%, p = 0.001). Post-artemisinin delayed haemolysis was reported in 19/70 (27%) patients treated with intravenous artesunate.
Conclusion: The majority of patients with severe malaria in this study were tourists or migrants acquiring the infection in West Africa. Intravenous artesunate is increasingly used for treatment of severe malaria in many European treatment centres and can be given safely to European patients with severe malaria. Patients treated with intravenous artesunate should be followed up to detect and manage late haemolytic events.
Simple Summary: Renal insufficiency is frequently seen in newly diagnosed multiple myeloma and can be due to the disease itself but also caused by medical interventions or infections. Patients with severe renal insufficiency are known to have an adverse prognosis, but recently, it was shown that even moderately impaired kidney function can have long-term sequelae. Achieving quick disease control by effective antimyeloma therapy can lead to the recovery of renal function. We investigated the kidney-specific variables in a large cohort of 770 myeloma patients receiving three different three-drug regimens for initial myeloma treatment to learn more about the differential effects on kidney function in an early disease phase. All regimens had a positive impact on kidney function without a difference in the proportion of patients who reached normal renal function after three cycles. Interestingly, patients who received bortezomib, lenalidomide, and dexamethasone tended to have higher risk for a worse renal function following induction when compared to the initial values.
Abstract: Background: Preservation of kidney function in newly diagnosed (ND) multiple myeloma (MM) helps to prevent excess toxicity. Patients (pts) from two prospective trials were analyzed, provided postinduction (PInd) restaging was performed. Pts received three cycles with bortezomib (btz), cyclophosphamide, and dexamethasone (dex; VCD) or btz, lenalidomide (len), and dex (VRd) or len, adriamycin, and dex (RAD). The minimum required estimated glomerular filtration rate (eGFR) was >30 mL/min. We analyzed the percent change of the renal function using the International Myeloma Working Group (IMWG) criteria and Kidney Disease: Improving Global Outcomes (KDIGO)-defined categories. Results: Seven hundred and seventy-two patients were eligible. Three hundred and fifty-six received VCD, 214 VRd, and 202 RAD. VCD patients had the best baseline eGFR. The proportion of pts with eGFR <45 mL/min decreased from 7.3% at baseline to 1.9% PInd (p < 0.0001). Thirty-seven point one percent of VCD versus 49% of VRd patients had a decrease of GFR (p = 0.0872). IMWG-defined “renal complete response (CRrenal)” was achieved in 17/25 (68%) pts after VCD, 12/19 (63%) after RAD, and 14/27 (52%) after VRd (p = 0.4747). Conclusions: Analyzing a large and representative newly diagnosed myeloma (NDMM) group, we found no difference in CRrenal that occurred independently from the myeloma response across the three regimens. A trend towards deterioration of the renal function with VRd versus VCD may be explained by a better pretreatment “renal fitness” in the latter group.
Results are presented on event-by-event electric charge fluctuations in central Pb+Pb collisions at 20, 30, 40, 80 and 158 AGeV. The observed fluctuations are close to those expected for a gas of pions correlated by global charge conservation only. These fluctuations are considerably larger than those calculated for an ideal gas of deconfined quarks and gluons. The present measurements do not necessarily exclude reduced fluctuations from a quark-gluon plasma because these might be masked by contributions from resonance decays.
Production of Lambda and Antilambda hyperons was measured in central Pb-Pb collisions at 40, 80, and 158 A GeV beam energy on a fixed target. Transverse mass spectra and rapidity distributions are given for all three energies. The Lambda/pi ratio at mid-rapidity and in full phase space shows a pronounced maximum between the highest AGS and 40 A GeV SPS energies, whereas the anti-Lambda}/pi ratio exhibits a monotonic increase. PACS numbers: 25.75.-q